Merck is scaling back its major operations in the UK, raising alarms about Britain’s capacity to retain its thriving life sciences sector amid rising costs and tangled regulations. Industry experts warn that this decision could put the future of the nation’s biotech industry at serious risk
The EU has launched a thorough investigation into France’s Sanofi, zeroing in on its vaccine business amid growing worries about anti-competitive practices. This bold step underscores the heightened scrutiny pharmaceutical giants are under in the post-pandemic world
UK Trade Secretary has launched a fierce critique of the pharmaceutical industry amid heated price negotiations, highlighting soaring drug costs and demanding fairer pricing as critical trade talks loom
Former President Donald Trump has introduced bold new drug tariffs aimed at dramatically cutting U.S. pharmaceutical prices. Experts weigh in on what these changes could mean for the cost of your medications at the pharmacy. Stay updated with USA Today
The US is preparing to impose new tariffs on pharmaceutical imports, kitchen cabinets, furniture, and heavy trucks, intensifying trade tensions. Stay tuned for live updates on how this bold move will impact industries and ignite reactions across the board
Indian pharma stocks plunged sharply following President Trump’s announcement of new drug tariffs. However, analysts urge investors not to panic, highlighting that this sell-off is largely sentiment-driven and the sector’s strong fundamentals remain intact despite the market turbulence
Japan proudly retains its most-favoured nation status for US pharmaceutical tariffs, unlocking valuable trade benefits, Akazawa confirms. This crucial designation not only ensures continued market access but also strengthens the robust bilateral trade partnership, TradingView reports
Brazil’s new clinical research law is transforming the industry by accelerating approvals, enhancing patient protections, and boosting transparency-positioning the country as a vibrant and competitive hotspot for global medical trials
Eli Lilly has temporarily paused UK orders of its diabetes medication Mounjaro ahead of an upcoming price hike, aiming to prevent potential stockpiling. This move carefully manages supply to meet rising demand while preparing for the new pricing structure
The US-Japan trade deal secures the lowest tariff rates ever on semiconductor chips and pharmaceuticals, a Japanese official revealed, setting the stage to turbocharge supply chains and strengthen economic ties, Reuters reports
Celltrion USA is excited to announce the U.S. debut of its denosumab biosimilars, STOBOCLO® and OSENVELT® (denosumab-bmwo), offering innovative and powerful new solutions for osteoporosis and bone health management
Charted: U.S. pharmaceutical drug imports from China highlight a growing dependence on vital raw materials and finished products. Visual Capitalist’s latest data uncovers the powerful trends reshaping the supply chain and transforming the market landscape
Indian-origin pharma magnate Tonmoy Sharma was arrested in Los Angeles for masterminding a massive $149 million healthcare fraud. Authorities say his intricate scheme has sent shockwaves through the US healthcare system, reports the Times of India
On a secluded island in China, cancer patients are embarking on a journey of hope as they take part in groundbreaking trials for cutting-edge experimental drugs. These pioneering therapies are not just treatments; they represent a bold leap forward in the fight against cancer, with the potential to revolutionize patient outcomes and bring new light to those facing limited options.
In a daring initiative to tackle soaring healthcare expenses, the US government is setting its sights on pharmaceutical companies, demanding significant reductions in drug prices. At the same time, India’s thriving generics market stands resilient and largely unaffected, prompting intriguing discussions about the shifting landscape of global pricing dynamics.
Exciting news from Lipocine Inc.! The company has just unveiled a groundbreaking license and supply agreement for its innovative testosterone replacement therapy, TLANDO®, in Brazil. This strategic partnership is set to broaden access to this vital treatment across the Brazilian market, significantly boosting Lipocine’s presence on the global stage.
An Indian drugmaker, once under the microscope of ProPublica, has announced a recall of two dozen medications that were sent to patients across the U.S. This alarming development has sparked fresh concerns about the safety and quality of drugs, especially in light of previous investigations that uncovered troubling issues within the company.
Chiesi has invested €430 million in a new facility in Italy, aiming to bolster its production capabilities. Meanwhile, Bharat Biotech has inaugurated its first cell and gene therapy (CGT) site in India, marking a significant advancement in the region’s biopharmaceutical landscape.
SNBL and Tasso, Inc. have announced a strategic joint venture in Japan aimed at advancing innovative healthcare solutions. This collaboration is set to enhance patient accessibility to advanced diagnostic tools in the region, strengthening both companies’ market presence.
Eli Lilly is set to introduce its weight-loss drug in emerging markets this year, aiming to address rising obesity rates. The launch follows successful outcomes in developed regions, positioning Lilly to expand its global footprint in the competitive weight management sector.
